全球生命科学和分析仪器市场 - 市场规模、份额、增长分析：按技术（NGS、PCR）、按用途（研究用途、临床/诊断用途） - 行业预测（2023-2030）

Global Life Sciences and Analytical Instruments Market Size, Share, Growth Analysis, By Technology(NGS, PCR), By Application(Research applications and Clinical & diagnostic applications) - Industry Forecast 2023-2030

出版日期: 2023年06月05日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2021年生命科学和分析仪器市场规模为714亿美元。预测该市场在预测期内（2023-2030年）将以7%的年复合成长率扩张，从2022年的765.6亿美元增长到2030年的1304.7亿美元。

生命科学和分析仪器应用于各个领域，包括实验室、医院、诊所、生物技术和製药公司。其用处在于对最终产品和原材料进行检验和检验。这些工具对于确保商品的质量和安全至关重要，可以在各个行业进行准确评估，同时防止潜在危险。

从地区来看，全球生命科学和分析仪器市场涵盖北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。值得注意的是，北美地区占据压倒性地位，2022 年约占市场收入的 38%。医药研发投入不断增加，行业龙头企业前景看好。此外，对产品完整性法规力度的加强正在加速食品和饮料行业的采用。在德国的带领下，欧洲在药物研究和技术进步方面蓬勃发展。在印度和中国的强劲扩张以及製药行业的进步的推动下，亚太地区呈现出强劲的增长势头。

生物技术和製药等行业投入了大量资源用于研发 (R&D)。其目的是加快药物研发并促进针对罕见疾病的创新疗法的推出。国际药品製造商协会联合会（IFPMA）报告称，製药行业每年的研发投资超过1500亿美元。已开发出7000多种新化合物，56种新药正在开发中。快速有效的生命科学工具在加速药物开发方面发挥着至关重要的作用，特别是针对心血管疾病、神经系统疾病、癌症和感染疾病，推动了全球生命科学和分析仪器市场的发展。

生命科学和分析仪器领域扩张的潜在要素包括设备成本急剧上升、公众健康意识下降以及可行替代方案的可用性。由于成本上升限制了采用、足够的认识限制了需求，以及可行替代方案的存在可能会驱使投资和兴趣远离传统生命科学和分析仪器，该行业的增长轨迹可能会受到这些要素的限制。

该报告审视了全球生命科学和分析仪器市场，提供了市场概述、技术趋势、用途、地区以及参与市场的公司概况。

主要企业简介
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- PerkinElmer Inc.
- Bruker Corporation
- Waters Corporation
- Shimadzu Corporation
- Merck KGaA
- GE Healthcare
- bioMerieux SA
- Hitachi High-Technologies Corporation
- Bio-Rad Laboratories Inc.
- Olympus Corporation
- Beckman Coulter Inc.
- Eppendorf AG
- Illumina Inc.
- Qiagen NV
- Becton, Dickinson and Company
- Hologic Inc.
- Sartorius AG

简介目录

Product Code: SQMIG35G2112

Life Sciences and Analytical Instruments Market size was valued at USD 71.4 billion in 2021 and is poised to grow from USD 76.56 billion in 2022 to USD 130.47 billion by 2030, growing at a CAGR of 7% in the forecast period (2023-2030).

Life science and analytical instruments find applications across diverse sectors such as laboratories, hospitals, clinics, as well as biotechnology and pharmaceutical companies. Their utility lies in the examination and validation of both end products and raw materials. These tools are pivotal in ensuring the quality and safety of goods, enabling precise evaluations in various industries while safeguarding against potential hazards. Global life sciences and analytical instruments market is segmented on the basis of technology, application and region. On the basis of Technology, global market is segmented into Spectroscopy, PCR, Next-Generation Sequencing (NGS), Microscopy, Flow Cytometry and Chromatography. On the basis of application, global market is segmented into research applications and clinical & diagnostic applications. On the basis of region, global market is divided into North America, Europe, Asia-Pacific, Latin America, and MEA.

Segmented by geography, the global market for life sciences and analytical instruments spans North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Notably, North America emerged as the dominant player, constituting approximately 38% of the market's revenue in 2022. Heightened investments in pharmaceutical R&D offer prospects for industry leaders. Additionally, escalated regulatory scrutiny regarding product integrity fuels adoption within the food and beverage sector. Europe, led by Germany, thrives on pharmaceutical research and technological strides. Asia-Pacific, driven by dynamic expansions in India and China, showcases robust growth attributed to advancing pharmaceutical industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Life Sciences and Analytical Instruments Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Driver:

Industries like biotechnology and pharmaceuticals are committing substantial resources to research and development (R&D) endeavors. This is aimed at expediting drug discovery and facilitating the innovative launch of therapeutic agents targeting rare ailments. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reports an annual R&D investment exceeding US$ 150 billion within the pharmaceutical sector. Over 7,000 novel compounds have been formulated, introducing 56 new drugs. Swift and effective life science tools play a pivotal role in hastening drug development, particularly for conditions such as cardiovascular diseases, neurological disorders, cancer, and infectious diseases, thereby propelling the global life sciences and analytical instruments market.

Restraint:

Anticipated impediments to the expansion of the life science and analytical equipment sector encompass escalating instrument expenditures, limited public health awareness, and the presence of feasible alternative options. The industry's growth trajectory might be constrained by these factors, as higher costs could deter adoption, insufficient awareness might limit demand, and the existence of viable alternatives could divert investment and interest away from traditional life science and analytical tools.

Key Market Trends:

Chromatography has gained prominence in analytical chemistry due to its remarkable attributes including precise separation capabilities, reproducibility, and rapid separation processes. A significant market trend involves its widespread application in pharmaceutical contexts, such as quantifying drug compounds. The rising utilization of chromatography assays in drug validation and augmented government funding bolster the market's anticipated expansion. These factors collectively underpin the projected market growth throughout the forecast period.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Life Sciences and Analytical Instruments Market by Technology
- Market Overview
- NGS
- PCR
- Spectroscopy
- Microscopy
Global Life Sciences and Analytical Instruments Market by Application
- Market Overview
- Research applications and Clinical & diagnostic applications
Global Life Sciences and Analytical Instruments Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Agilent Technologies Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Thermo Fisher Scientific Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Danaher Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- PerkinElmer Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bruker Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Waters Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Shimadzu Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck KGaA
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GE Healthcare
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- bioMerieux SA
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Hitachi High-Technologies Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bio-Rad Laboratories Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Olympus Corporation
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Beckman Coulter Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eppendorf AG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Illumina Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Qiagen N.V.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Becton, Dickinson and Company
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Hologic Inc.
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sartorius AG
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- On August 1, 2022, Thermo Fisher Scientific, Inc., a global leader in scientific services, introduced the Thermo Scientific Arctis Cryo-Plasma Focused Ion Beam (Cryo-PFIB), a new network and automated microscope designed to accelerate cryo-electron tomography (Cryo-ET) research
Company Overview
Business Segment Overview
Financial Updates
Key Developments